Evidence map›Paper›PMID 11899428›Full record

ArticleImmunology2001

Blockage of complement regulators in the conjunctiva and within the eye leads to massive inflammation and iritis.

D S Bardenstein, C J Cheyer, C Lee, E Cocuzzi, M Mizuno, N Okada, M E Medof

Open access · greenAbstract read
In one paragraph

Article in Immunology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

D S BardensteinInstitute of Pathology, Center for Vision Research, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
C J Cheyer
C Lee
E Cocuzzi
M Mizuno
N Okada
M E Medof
Case Western Reserve University · USNagoya City University · JPUniversity School · US

Funding

TISSUE CULTURE AND HYBRIDOMA MODULEP30EY011373 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI Irina A Pikuleva · 1997 to 2026
$17.7M
PROTECTION OF THE OCULAR SURFACER01EY011288 · NEI · CASE WESTERN RESERVE UNIVERSITY · PI MEDOF, MELVIN EDWARD · 1996 to 2006
$1.5M
NEI NIH HHS EY11288NEI NIH HHS EY11373NEI NIH HHS P30 EY011373NEI NIH HHS R01 EY011288
6 · The paper itself

Abstract

The open environment of the eye is continuously subject to an influx of foreign agents that can activate complement. Decay-accelerating factor (DAF), membrane cofactor protein (MCP) and CD59 are regulators that protect self-cells from autologous complement activation on their surfaces. They are expressed in the eye at unusually high levels but their physiological importance in this site is unstudied. In the rat, a structural analogue termed 5I2 antigen (5I2 Ag) has actions overlapping DAF and MCP. In this investigation, we injected F(ab')2 fragments of 5I2 mAb into the conjunctiva and aqueous humor, in the latter case with and without concomitant blockage of CD59. Massive neutrophilic infiltration of the stroma and iris resulted upon blocking 5I2 Ag activity. Frank necrosis of the iris occurred upon concomitant intraocular blockage of CD59. C3b was identified immunohistochemically, and minimal effects were seen in complement-depleted animals and in those treated with non-relevant antibody. The finding that blockage of 5I2 Ag function in periocular tissues and within the eye causes intense conjunctival inflammation and iritis demonstrates the importance of intrinsic complement regulators in protecting ocular tissues from spontaneous or bystander attack by autologous complement.

Indexed as

AnimalsAntibodies, MonoclonalAntigens, SurfaceCD59 AntigensComplement ActivationConjunctivaConjunctivitisEyeImmune ToleranceImmunoglobulin Fab FragmentsIritisMiceNeutrophil InfiltrationRatsReceptors, Cell SurfaceReceptors, ComplementAntibodies, MonoclonalAntigens, SurfaceCD59 AntigensCr1l protein, mouseCr1l protein, ratImmunoglobulin Fab FragmentsReceptors, Cell SurfaceReceptors, ComplementReceptors, Complement 3b

Identifiers

PMID11899428
PMCPMC1783320
OpenAlexW2003985640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.